quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·1421d
PRRelease
Agios Pharmaceuticals Inc. logo
Array Technologies Inc. logo
Atara Biotherapeutics Inc. logo
+2

Qiming Venture Partners USA Announces $260 Million US Healthcare Fund III and Addition of New Partner, Isaac Ciechanover

AGIO· Agios Pharmaceuticals Inc.ARRY· Array Technologies Inc.ATRA· Atara Biotherapeutics Inc.PTCT· PTC Therapeutics Inc.XLRN· Acceleron Pharma Inc.
Health CareConsumer Discretionary
Original source

Companies

  • AGIO
    Agios Pharmaceuticals Inc.
    Health Care
  • ARRY
    Array Technologies Inc.
    Consumer Discretionary
  • ATRA
    Atara Biotherapeutics Inc.
    Health Care
  • PTCT
    PTC Therapeutics Inc.
    Health Care
  • XLRN
    Acceleron Pharma Inc.
    Health Care

Recent analyst ratings

  • Apr 20AGIOUpdateH.C. Wainwright$50.00
  • Apr 10PTCTUpdateRaymond James$108.00
  • Feb 26ARRYUpdateDeutsche Bank$9.00
  • Feb 25ARRYUpdateBNP Paribas Exane$19.00
  • Jan 28PTCTUpdateBarclays$119.00
  • Jan 28ARRYUpdateRobert W. Baird$11.00

Related

  • INSIDER6h
    CHIEF EXECUTIVE OFFICER Klein Matthew B. sold $202,094 worth of shares (2,850 units at $70.91), decreasing direct ownership by 0.72% to 394,070 units (SEC Form 4) to satisfy withholding tax
  • PR1d
    PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
  • SEC3d
    SEC Form DEFA14A filed by PTC Therapeutics Inc.
  • SEC3d
    SEC Form DEF 14A filed by PTC Therapeutics Inc.
  • ANALYST3d
    H.C. Wainwright reiterated coverage on Agios Pharma with a new price target
  • PR6d
    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • PR8d
    ARRAY Technologies, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call
  • ANALYST13d
    Raymond James initiated coverage on PTC Therapeutics with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022